How does one evaluate change in the price of a cataract operation over a ten-year period when the nature of the procedure and its impact on the patient has changed so radically? Indeed, how will we measure inflation, and the associated financial and real implications, in the twentyfirst century when our data--using current techniques--could become increasingly less adequate for tracing price trends over time?
Supervision should be tightened too, to ensure that a closer watch is kept on the strategy and corporate culture of supervised institutions, but also that more account is taken of the macro-environment in which financial institutions operate. Let me conclude.